Loading stock research
Loading stock research…
No token price observed
Observation time unavailableUnavailable
Underlying share reference$257.51(Jupiter stock data)
A reference quote for STE, not a price you can trade the token at.
Updated · Source: Jupiter stock data
Buy from your own wallet on Solana mainnet. You review and sign every transaction.
Checking whether mainnet purchases are available…
You sign in your own wallet. Ovelo never holds your keys or funds.
Daily closes of STE, the underlying share. A token’s rights, price and liquidity can differ from the share.
Research observed · Source: Yahoo Finance, Wikipedia (CC BY-SA)
What you would hold, where it trades and where these numbers come from.
Observation time unavailableUnavailable
The company behind STE.
Steris plc is an American-Irish-based medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, and has been legally registered in Dublin, Ireland, for tax purposes since 2018. Previously the company was registered in the United Kingdom from 2014 to 2018. Steris is listed on the New York Stock Exchange, and is a constituent of the S&P 500 Index. As of 2024, the president and CEO is Daniel A. Carestio.
Observed · Source: Company profile
Momentum from daily closes of the underlying share.
Computed from daily closes of the underlying share, not the token. Not a recommendation.
Close of · Source: Yahoo Finance daily closesStale
Reported financials. They describe the company, not the token’s market value.
| Item | Period end | Value |
|---|---|---|
| Revenue (annual) | 31 Mar 2026 | $5.94B |
| Revenue (annual) | 31 Mar 2025 | $5.46B |
| Revenue (annual) | 31 Mar 2024 | $5.14B |
| Revenue (annual) | 31 Mar 2023 | $4.54B |
| Net income (annual) | 31 Mar 2026 | $782.30M |
| Net income (annual) | 31 Mar 2025 | $614.70M |
| Net income (annual) | 31 Mar 2024 | $378.30M |
| Net income (annual) | 31 Mar 2023 | $107.03M |
| Diluted EPS (annual) | 31 Mar 2026 | 7.93 USD/share |
| Diluted EPS (annual) | 31 Mar 2025 | 6.20 USD/share |
| Diluted EPS (annual) | 31 Mar 2024 | 3.81 USD/share |
| Diluted EPS (annual) | 31 Mar 2023 | 1.07 USD/share |
| Total assets (annual) | 31 Mar 2026 | $10.74B |
| Total assets (annual) | 31 Mar 2025 | $10.15B |
| Total assets (annual) | 31 Mar 2024 | $11.06B |
| Total assets (annual) | 31 Mar 2023 | $10.82B |
| Total debt (annual) | 31 Mar 2026 | $2.09B |
| Total debt (annual) | 31 Mar 2025 | $2.20B |
| Total debt (annual) | 31 Mar 2024 | $3.38B |
| Total debt (annual) | 31 Mar 2023 | $3.25B |
| Operating cash flow (annual) | 31 Mar 2026 | $1.34B |
| Operating cash flow (annual) | 31 Mar 2025 | $1.15B |
| Operating cash flow (annual) | 31 Mar 2024 | $973.30M |
| Operating cash flow (annual) | 31 Mar 2023 | $756.95M |
| Free cash flow (annual) | 31 Mar 2026 | $972.40M |
| Free cash flow (annual) | 31 Mar 2025 | $778.00M |
| Free cash flow (annual) | 31 Mar 2024 | $613.00M |
| Free cash flow (annual) | 31 Mar 2023 | $394.98M |
| Revenue (quarterly) | 30 Sept 2026 | $1.59B |
| Revenue (quarterly) | 30 Jun 2026 | $1.49B |
| Revenue (quarterly) | 31 Mar 2026 | $1.59B |
| Revenue (quarterly) | 31 Dec 2025 | $1.50B |
| Revenue (quarterly) | 30 Sept 2025 | $1.46B |
| Net income (quarterly) | 30 Sept 2026 | $213.70M |
| Net income (quarterly) | 30 Jun 2026 | $200.10M |
| Net income (quarterly) | 31 Mar 2026 | $220.20M |
| Net income (quarterly) | 31 Dec 2025 | $192.80M |
| Net income (quarterly) | 30 Sept 2025 | $191.90M |
| Diluted EPS (quarterly) | 30 Sept 2026 | 2.19 USD/share |
| Diluted EPS (quarterly) | 30 Jun 2026 | 2.04 USD/share |
| Diluted EPS (quarterly) | 31 Mar 2026 | 2.24 USD/share |
| Diluted EPS (quarterly) | 31 Dec 2025 | 1.96 USD/share |
| Diluted EPS (quarterly) | 30 Sept 2025 | 1.94 USD/share |
Reported dividends, splits and filings, each linked to its source.
Recent headlines about the company.